These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23885741)

  • 21. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
    Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P
    Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
    Feely MG; O'Dell JR
    Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacotherapy of patients with (early) rheumatoid arthritis].
    Jacobs JW; Blaauw AA; Dijkmans BA; van Riel PL; Bijlsma JW
    Ned Tijdschr Geneeskd; 2000 Jan; 144(5):211-6. PubMed ID: 10682647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspectives on rheumatoid arthritis for the orthopedic surgeon: overview of early diagnosis and the tumor necrosis factor antagonists.
    Keith MP
    Am J Orthop (Belle Mead NJ); 2011 Sep; 40(9):E193-5. PubMed ID: 22022685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target.
    Pincus T; Castrejón I
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S33-40. PubMed ID: 24219039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease-modifying anti-rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community-based practice.
    Montag K; Gingold M; Boers A; Littlejohn G
    Intern Med J; 2011 Jun; 41(6):450-5. PubMed ID: 20403067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of early rheumatoid arthritis.
    Brown AN
    J S C Med Assoc; 2003 Oct; 99(10):296-302. PubMed ID: 14621660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up.
    Tiippana-Kinnunen T; Paimela L; Kautiainen H; Laasonen L; Leirisalo-Repo M
    Scand J Rheumatol; 2010; 39(1):12-8. PubMed ID: 20132065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antirheumatic drugs and the risk of tuberculosis.
    Brassard P; Kezouh A; Suissa S
    Clin Infect Dis; 2006 Sep; 43(6):717-22. PubMed ID: 16912945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
    Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
    Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients.
    Aletaha D; Funovits J; Keystone EC; Smolen JS
    Arthritis Rheum; 2007 Oct; 56(10):3226-35. PubMed ID: 17907167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis: results from a multicenter, randomized study.
    Mandl P; Balint PV; Brault Y; Backhaus M; D'Agostino MA; Grassi W; van der Heijde D; de Miguel E; Wakefield RJ; Logeart I; Dougados M
    Arthritis Care Res (Hoboken); 2013 Jun; 65(6):879-87. PubMed ID: 23213004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of treatment for rheumatoid arthritis.
    Upchurch KS; Kay J
    Rheumatology (Oxford); 2012 Dec; 51 Suppl 6():vi28-36. PubMed ID: 23221584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and management of rheumatoid arthritis.
    Rindfleisch JA; Muller D
    Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic strategies in early rheumatoid arthritis.
    Smolen JS; Aletaha D; Machold KP
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):163-77. PubMed ID: 15588977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical approach to a patient with rheumatoid arthritis].
    Perković D; Kaliterna DM; Krstulović DM; Bozić I; Borić K; Radić M
    Reumatizam; 2014; 61(2):24-30. PubMed ID: 25427391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid arthritis: treating to target with disease-modifying drugs.
    Firth J
    Br J Nurs; 2011 Oct 28-Nov 9; 20(19):1240, 1242, 1244-5. PubMed ID: 22067836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.